Skip to main content
. 2023 Oct 18;6:1058. doi: 10.1038/s42003-023-05317-9

Fig. 5. S-Calpeptin treatment reduces viral load in trachea in a hamster SARS-CoV-2 infection model.

Fig. 5

Golden Syrian hamsters were intranasally inoculated with SARS-CoV-2 on day 0. Daily treatment started on day 1 with 1 mg/kg S-Calpeptin subcutaneously (s.c.) and 1:100 DMSO (dimethyl sulfoxide) as control. Viral load was measured at day 3, 5, and 7 post infection in lungs and trachea. a SARS-CoV-2 RNA level expressed as viral RNA copies/copies of β-actin/g of tissue. b Infectious viral particles expressed as 50% tissue culture infective dose/g of tissue. n = 5 animals per group. Values are expressed in median, interquartiles and range. Statistically significant differences (p ≤ 0.05) were determined by two-sided Mann–Whitney U-test.